Q BioMed Inc (QBIO)

[taegher]

This NEWS from B.com is dramatic for QBIO - This NEWS just out last evening AH on Briefing.com - Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse. FDA Release
The timing of this new drug QBIO just got approved to sell is huge!